Mucormycosis during Coronavirus Disease pandemic: A diagnosis we cannot afford to miss
Mucormycosis is a very aggressive, devastating opportunistic fungal infection commonly involving nasal, maxillary,orbital, and cerebral regions. In the second wave of the coronavirus disease 2019 (COVID-19) pandemic, a high frequency of mucormycosis infections has been seen because of the triad of C...
Guardado en:
Autores principales: | Kaneesh Karthik Arthanari, Sivakumar Annamalai, Arthiie Thangavelu, Chandrika Palanivelu, Gowtham Suresh, Sambavi Anbuselvan |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Wolters Kluwer Medknow Publications
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e03bf5f88a0149ebad1efb12b2e4b53f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Pulmonary Mucormycosis as the Leading Clinical Type of Mucormycosis in Western China
por: Junyan Qu, et al.
Publicado: (2021) -
Rhino-orbito-cerebral Mucormycosis: Pictorial Review
por: Vivek Pai, et al.
Publicado: (2021) -
Mucormycosis in Hematologic Malignancies: Clinical Follow-Up and Treatment Results
por: Nagehan Didem Sarı, et al.
Publicado: (2021) -
Inhibition of EGFR Signaling Protects from Mucormycosis
por: Tonya N. Watkins, et al.
Publicado: (2018) -
From the editorial desk
por: Gobichettipalayam Jegatheeswaran Anbuselvan, et al.
Publicado: (2021)